ClearPoint Neuro, Inc.
CLPT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001285550
No open-market purchases or sales by ClearPoint Neuro, Inc. insiders were filed in the last 90 days; 128 institutions reported holding it in 13F filings for Q2 2026, worth $247.8M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding ClearPoint Neuro, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 50 | 76 | +26 |
| Shares | 3.10M | 5.36M | +2.26M (+72.8%) |
| Value | $65.6M | $102.3M | +$36.7M (+55.9%) |
New holders (35)
Institutions that held ClearPoint Neuro, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (9)
Institutions that held ClearPoint Neuro, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| ExodusPoint Capital Management, LP | 45,536 | $963.0K |
| HRT Financial LP | 38,336 | $810.0K |
| Peapack Gladstone Financial Corp | 12,730 | $269.0K |
| Ieq Capital, LLC | 9,733 | $206.0K |
| Total Clarity Wealth Management, Inc. | 5,534 | $117.0K |
| Dorsey Wright & Associates | 3,069 | $64.9K |
| Maven Securities LTD | 1,507 | $32.0K |
| First Quadrant L P | 1,116 | $24.0K |
| Federated Hermes, Inc. | 330 | $7.00K |